Delivery Order SPE2DB22D1017-SPE2DB25FG4US
Award Date
6/11/25
Potential Completion Date
6/12/25
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,224.16 firm fixed-price delivery order is for the supply of 4,567,390,794 units of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,036.59, is for the delivery of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, with a completion date of May 20, 2025. The award is not set aside and involves open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order valued at $22,275.47, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CELLCEPT 500 MG TABLET 100S, a prescription medication, with a performance period extending through May 20, 2025. The contract is noted as having no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, with a ceiling value of $16,682.31 and a period of performance through May 13, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing structure and does not have a set-aside designation, indicating open competition....
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,363.12 delivery order contract is for the supply of CELLCEPT 500 MG TABLET 100S, a specialty medication. The contract has a firm fixed price and a completion date of March 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award, valued at $3,451.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,069.14 firm fixed-price delivery order contract is for the supply of CELLCEPT 500 MG TABLET 100S, a specialty medication. The contract has an ultimate completion date of December 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $11,756.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of CELLCEPT 500 MG TABLET 100S, with an ultimate completion date of June 6, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not a set-aside contract. The company also holds a significant Indefinite Delivery Contract...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,727.86 firm fixed-price delivery order is for 4,568,521,542 units of the drug CELLCEPT 500 MG TABLET 100S. The contract has a completion date of June 12, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,339.68 Firm Fixed Price Delivery Order contract is for the supply of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...